Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cellsS Asano, Yukio Ago, Kotaro Sakamoto et al.|Journal of Pharmacological Sciences|2024Cited by 10
Dimerisation of the VIP receptor VIPR2 is essential to its binding VIP and Gα<sub>i</sub> proteins, and to its functions in breast cancer cellsS Asano, Yukio Ago, Kairi Ozasa et al.|British Journal of Pharmacology|2025Cited by 3